Evidence map›Paper›PMID 35347433›Full record

ArticleMikrochimica acta2022

In situ vertical alignment of 2D MoS

Zhihui Mao, Han Zhu, Xinsheng Peng, Jie Chen, Qiang Chen, XiaoBing Chen, Xiaojun Hu, Hongxia Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Studying Peptide-Metal Ion Complex Structures by Solution-State NMR.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhihui MaoSchool of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China.
Han ZhuCenter for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, Shanghai, 200444, China.
Xinsheng PengSchool of Medicine, Shanghai University, Shanghai, 200444, China.
Jie ChenCenter for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, Shanghai, 200444, China.
Qiang ChenSchool of Medicine, Shanghai University, Shanghai, 200444, China.
XiaoBing ChenDepartment of Oncology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, China.
Xiaojun HuCenter for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, Shanghai, 200444, China.
Hongxia ChenCenter for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, Shanghai, 200444, China. hxchen@shu.edu.cn.ORCID http://orcid.org/0000-0003-2400-9061

Funding

National Natural Science Foundation of China 61875114National Natural Science Foundation of China 62005156
6 · The paper itself

Abstract

There is an urgent need for a flexible and simple programmed cell death ligand 1 (PD-L1) dynamic measurement method enabling real-time monitoring of cancer progression and assessment of immunotherapy efficacy. In the current study, we show facile in situ synthesis of vertical alignment two-dimensional molybdenum disulfide (2D MoS

Indexed as

Biosensing TechniquesMolybdenumB7-H1 AntigenReproducibility of ResultsB7-H1 AntigenMolybdenum2D nanomaterialsHigh-probe capturingIn-plane electron transportPD-L1 recognitionVertical alignment

Identifiers

PMID35347433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.